s6y ACURA PHARMACEUTICALS, INC 10-K

ACURA PHARMACEUTICALS, INC 10-K, filed Jun 7, 2018: IDEA: XBRL DOCUMENT

NET LOSS PER SHARE OF COMMON STOCK (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Net loss per share - basic                    
Numerator: net loss $ (1,738) $ (2,200) $ (2,149) $ 405 $ 1,534 $ (2,250) $ (3,288) $ (3,384) $ (5,682) $ (7,388)
Denominator (weighted):                    
Common shares                 15,790 11,834
Vested RSUs                 113 36
Basic weighted average shares outstanding                 15,903 11,870
EPS - basic $ (0.08) $ (0.12) $ (0.18) $ 0.03 $ 0.13 $ (0.19) $ (0.28) $ (0.28) $ (0.36) $ (0.62)
Net loss per share - assuming dilution                    
Numerator: net loss $ (1,738) $ (2,200) $ (2,149) $ 405 $ 1,534 $ (2,250) $ (3,288) $ (3,384) $ (5,682) $ (7,388)
Denominator (weighted):                    
Common shares                 15,790 11,834
Vested RSUs                 113 36
Stock options                 0 0
Common stock warrants                 0 0
Diluted weighted average shares outstanding                 15,903 11,870
Net loss per share - diluted $ (0.08) $ (0.12) $ (0.18) $ 0.03 $ 0.13 $ (0.19) $ (0.28) $ (0.28) $ (0.36) $ (0.62)
Excluded dilutive securities, Common stock issuable (non-weighted):                    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount                 3,536 1,457
Restricted Stock Units (RSUs) [Member]                    
Excluded dilutive securities, Common stock issuable (non-weighted):                    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount                 200 0
Employee Stock Option [Member]                    
Excluded dilutive securities, Common stock issuable (non-weighted):                    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount                 1,494 1,397
Warrant [Member]                    
Excluded dilutive securities, Common stock issuable (non-weighted):                    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount                 1,842 60